Who owns HALOZYME THERAPEUTICS?
- CUSIP Number: 40637had1
Tip: Access positions for across all investors
Analyze quarterly positions in Halozyme Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Halozyme Therapeutics stock
Who bought or sold HALOZYME THERAPEUTICS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Steelhead Partners | 112M | $128B | 72% | Sep 2025 |
|
| Opti Capital Management | 73M | $84B | 3% | Sep 2025 |
|
| Linden Advisors | 68M | $78M | -31% | Sep 2025 |
|
| Millennium Management | 59M | $68M | 137% | Sep 2025 |
|
| DeepCurrents Investment Group | 45M | $52M | 100% | Sep 2025 |
|
| Tenor Capital Management | 45M | $51M | 163% | Sep 2025 |
|
| BlackRock | 41M | $47M | 17% | Sep 2025 |
|
| Lazard Asset Management | 39M | $445k | -37% | Sep 2025 |
|
| M&G | 37M | $43M | 100% | Sep 2025 |
|
| UBS O'Connor | 18M | $21M | 100% | Sep 2025 |
|
| Jpmorgan Chase & Co | 17M | $20M | 100% | Sep 2025 |
|
| State Street Corporation | 17M | $19M | 10% | Sep 2025 |
|
| Ameriprise Financial | 12M | $14M | 66667% | Sep 2025 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 11M | $12M | 13% | Sep 2025 |
|
| FMR | 9.2M | $11M | -6% | Sep 2025 |
|
| Calamos Advisors | 5.7M | $6.2M | -80% | Dec 2025 |
|
| MacKay Shields | 5.2M | $5.6M | -90% | Dec 2025 |
|
| Angelo, Gordon & Co | 5.0M | $5.7M | 100% | Sep 2025 |
|
| Point72 Asset Management | 5.0M | $5.7M | -93% | Sep 2025 |
|
| Sonora Investment Management Group | 3.8M | $4.4M | -5% | Sep 2025 |
|
| Water Island Capital | 3.0M | $3.4M | 0% | Sep 2025 |
|
| State of Wisconsin Investment Board | 3.0M | $3.4M | 50% | Sep 2025 |
|
| Bnp Paribas Investment Partners | 2.7M | $3.1M | 0% | Sep 2025 |
|
| Palisade Capital Management | 2.6M | $3.0M | 0% | Sep 2025 |
|
| Pier 88 Investment Partners | 2.5M | $2.7M | 3437% | Dec 2025 |
|
| Huntington Asset Advisors | 2.4M | $2.6M | 100% | Dec 2025 |
|
| Man Group | 2.3M | $2.7M | -11% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 2.1M | $2.4M | -90% | Sep 2025 |
|
| Aequim Alternative Investments | 2.0M | $2.3M | 100% | Sep 2025 |
|
| Deutsche Bank Aktiengesellschaft | 2.0M | $2.3M | -45% | Sep 2025 |
|
| Wells Fargo & Company | 1.5M | $1.7M | -47% | Sep 2025 |
|
| Macquarie Group | 1.2M | $1.4M | 100% | Sep 2025 |
|
| Flossbach Von Storch | 1.1M | $1.1M | -40% | Dec 2025 |
|
| Kohlberg Kravis Roberts & Co | 915k | $1.1M | 46% | Sep 2025 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 750k | $812k | -95% | Dec 2025 |
|
| Nomura Holdings | 504k | $37M | 65% | Sep 2025 |
|
| Jane Street | 475k | $548k | -93% | Sep 2025 |
|
| Calamos Wealth Management | 262k | $284k | 1% | Dec 2025 |
|
| Oppenheimer Asset Management | 175k | $189k | 0% | Dec 2025 |
|
| Wiley Bros.-aintree Capital | 131k | $150k | -5% | Sep 2025 |
|
| Cetera Investment Advisers | 118k | $135k | -6% | Sep 2025 |
|
| Cutler Capital Management | 110k | $126k | 0% | Sep 2025 |
|
| Capital Investment Advisory Services | 59k | $64k | 0% | Dec 2025 |
|
| Mariner Wealth Advisors | 59k | $68k | 9% | Sep 2025 |
|
| SSI Investment Management | 57k | $65k | 0% | Sep 2025 |
|
| Stephens | 53k | $57k | 0% | Dec 2025 |
|
| Leucadia National Corporation | 43k | $49k | -99% | Sep 2025 |
|
| Branch Banking & Trust Company | 38k | $41k | 0% | Dec 2025 |
|
| Balboa Wealth Partners | 28k | $30k | 0% | Dec 2025 |
|
| Wealth Enhancement Advisory Services | 21k | $24k | 110% | Dec 2025 |
|
| Laffer Investments | 20k | $2.3M | 901% | Sep 2025 |
|
| Boussard & Gavaudan Investment Management | 20k | $22M | -45% | Sep 2025 |
|
| MAI Wealth Advisors | 15k | $17k | 0% | Sep 2025 |
|
| Goldstein Advisors | 14k | $15k | 100% | Dec 2025 |
|
| CoreCap Advisors | 5.0k | $5.4k | 100% | Dec 2025 |
|
| Erste Asset Management GmbH | 0 | $0 | -100% | Sep 2025 |
|
Who sold out of Halozyme Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Jun 2025 | 25M | $25M |
| Wellesley Investment Advisors | Sep 2025 | 23M | $27B |
| Advent Capital Management | Jun 2025 | 17M | $17M |
| Camden Asset Management | Jun 2025 | 12M | $12B |
| Jain Global | Jun 2025 | 7.5M | $7.5M |
| Shenkman Capital Management | Sep 2025 | 3.6M | $4.2B |
| New York State Common Retirement Fund | Jun 2025 | 3.2M | $3.2M |
| Amundi | Jun 2025 | 2.8M | $2.8M |
| Lombard Odier Asset Management | Jun 2025 | 2.5M | $2.5M |
| Oaktree Capital Management | Jun 2025 | 2.0M | $2.0M |
| Sei Investments | Sep 2025 | 427k | $488k |
| Bank of New York Mellon | Sep 2025 | 200k | $231k |
| HPM Partners | Jun 2025 | 43k | $43k |
| Foresight Capital Management Advisors | Sep 2025 | 30k | $35k |
| Rsm Us Wealth Management | Sep 2025 | 28k | $32k |
| Brian McDonald | Sep 2025 | 10k | $11k |